2023 Q2 Form 10-Q Financial Statement

#000104097123000020 Filed on May 05, 2023

View on sec.gov

Income Statement

Concept 2023 Q2 2023 Q1
Revenue $221.1M $223.6M
YoY Change 9.74% 18.95%
Cost Of Revenue $93.50M $99.75M
YoY Change 21.66% 24.85%
Gross Profit $127.6M $123.8M
YoY Change 2.39% 14.58%
Gross Profit Margin 57.71% 55.38%
Selling, General & Admin $23.01M $23.30M
YoY Change -2.1% -6.05%
% of Gross Profit 18.03% 18.82%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $71.24M $80.57M
YoY Change 45.89% 64.66%
% of Gross Profit 55.84% 65.07%
Operating Expenses $92.09M $23.30M
YoY Change 291.88% -6.05%
Operating Profit $35.48M $100.5M
YoY Change -64.9% 20.72%
Interest Expense -$82.12M $64.84M
YoY Change -352.19% 102.31%
% of Operating Profit -231.43% 64.5%
Other Income/Expense, Net -$305.9M
YoY Change
Pretax Income -$379.2M -$38.36M
YoY Change 899.31% -384.44%
Income Tax $2.000M $800.0K
% Of Pretax Income
Net Earnings -$360.6M -$35.99M
YoY Change 798.38% -413.28%
Net Earnings / Revenue -163.12% -16.1%
Basic Earnings Per Share -$5.63 -$0.63
Diluted Earnings Per Share -$5.63 -$0.63
COMMON SHARES
Basic Shares Outstanding 64.38M shares 64.37M shares
Diluted Shares Outstanding 68.34M shares 68.18M shares

Balance Sheet

Concept 2023 Q2 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $192.0M $169.2M
YoY Change -10.96% -34.05%
Cash & Equivalents $192.0M $158.9M
Short-Term Investments $9.797M $10.27M
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $326.2M $329.7M
Other Receivables $0.00 $0.00
Total Short-Term Assets $518.2M $488.6M
YoY Change 2.1% -18.08%
LONG-TERM ASSETS
Property, Plant & Equipment $4.967B $7.143B
YoY Change -9.34% 23.97%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $3.875B $3.165B
YoY Change 26.05% 5.46%
Other Assets $231.4M $315.9M
YoY Change 12.05% 53.41%
Total Long-Term Assets $9.523B $11.85B
YoY Change -6.61% 13.77%
TOTAL ASSETS
Total Short-Term Assets $518.2M $488.6M
Total Long-Term Assets $9.523B $11.85B
Total Assets $10.04B $12.34B
YoY Change -6.2% 12.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $116.7M $150.9M
YoY Change -19.65% 8.18%
Accrued Expenses $906.0M $909.0M
YoY Change 4.81% 4.04%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.094B $1.132B
YoY Change 0.5% 3.78%
LONG-TERM LIABILITIES
Long-Term Debt $3.910B $5.682B
YoY Change -1.89% 35.87%
Other Long-Term Liabilities $456.4M $547.8M
YoY Change 23.63% 21.49%
Total Long-Term Liabilities $4.366B $6.230B
YoY Change 0.27% 34.47%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.094B $1.132B
Total Long-Term Liabilities $4.366B $6.230B
Total Liabilities $5.782B $7.362B
YoY Change 6.22% 28.62%
SHAREHOLDERS EQUITY
Retained Earnings $135.5M $549.0M
YoY Change -82.63% -35.15%
Common Stock $656.0K $656.0K
YoY Change 0.15% 0.46%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.259B $4.460B
YoY Change
Total Liabilities & Shareholders Equity $10.04B $12.34B
YoY Change -6.2% 12.05%

Cashflow Statement

Concept 2023 Q2 2023 Q1
OPERATING ACTIVITIES
Net Income -$360.6M -$35.99M
YoY Change 798.38% -413.28%
Depreciation, Depletion And Amortization $71.24M $80.57M
YoY Change 45.89% 64.66%
Cash From Operating Activities $61.64M $42.35M
YoY Change -38.99% -47.98%
INVESTING ACTIVITIES
Capital Expenditures $72.27M $61.92M
YoY Change -210.72% -200.39%
Acquisitions
YoY Change
Other Investing Activities $99.77M -$4.451M
YoY Change -46.68% -105.92%
Cash From Investing Activities $27.50M -$66.37M
YoY Change -77.43% -591.77%
FINANCING ACTIVITIES
Cash Dividend Paid $57.37M
YoY Change -13.52%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -135.3M -$2.772M
YoY Change -46.53% -97.77%
NET CHANGE
Cash From Operating Activities 61.64M $42.35M
Cash From Investing Activities 27.50M -$66.37M
Cash From Financing Activities -135.3M -$2.772M
Net Change In Cash -46.20M -$26.79M
YoY Change 52.7% -9.69%
FREE CASH FLOW
Cash From Operating Activities $61.64M $42.35M
Capital Expenditures $72.27M $61.92M
Free Cash Flow -$10.63M -$19.57M
YoY Change -106.39% -113.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001040971
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
1-13199
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
SL GREEN REALTY CORP
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3956775
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
One Vanderbilt Avenue
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10017
CY2023Q1 dei City Area Code
CityAreaCode
212
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
594-2700
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
64375527 shares
CY2023Q1 us-gaap Land
Land
1576927000 usd
CY2022Q4 us-gaap Land
Land
1576927000 usd
CY2023Q1 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
4940138000 usd
CY2022Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
4903776000 usd
CY2023Q1 slg Building Leasehold Improvements Gross
BuildingLeaseholdImprovementsGross
1700376000 usd
CY2022Q4 slg Building Leasehold Improvements Gross
BuildingLeaseholdImprovementsGross
1691831000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1026265000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1026265000 usd
CY2023Q1 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
9243706000 usd
CY2022Q4 us-gaap Real Estate Investment Property At Cost
RealEstateInvestmentPropertyAtCost
9198799000 usd
CY2023Q1 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2100804000 usd
CY2022Q4 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2039554000 usd
CY2023Q1 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
7142902000 usd
CY2022Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
7159245000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
158937000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
203273000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
198325000 usd
CY2022Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
180781000 usd
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
10273000 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
11240000 usd
CY2023Q1 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
36289000 usd
CY2022Q4 us-gaap Accounts And Notes Receivable Net
AccountsAndNotesReceivableNet
34497000 usd
CY2023Q1 us-gaap Due From Related Parties
DueFromRelatedParties
26794000 usd
CY2022Q4 us-gaap Due From Related Parties
DueFromRelatedParties
27352000 usd
CY2023Q1 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
266567000 usd
CY2022Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
257887000 usd
CY2023Q1 slg Discount Of Structured Finance Investments
DiscountOfStructuredFinanceInvestments
1689000 usd
CY2022Q4 slg Discount Of Structured Finance Investments
DiscountOfStructuredFinanceInvestments
1811000 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
13520000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
6630000 usd
CY2023Q1 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
626803000 usd
CY2022Q4 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
623280000 usd
CY2023Q1 us-gaap Equity Method Investments
EquityMethodInvestments
3164729000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3190137000 usd
CY2023Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
117602000 usd
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
121157000 usd
CY2023Q1 us-gaap Other Assets
OtherAssets
592898000 usd
CY2022Q4 us-gaap Other Assets
OtherAssets
546945000 usd
CY2023Q1 us-gaap Assets
Assets
12342119000 usd
CY2022Q4 us-gaap Assets
Assets
12355794000 usd
CY2023Q1 us-gaap Secured Debt
SecuredDebt
3226781000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
3227563000 usd
CY2023Q1 us-gaap Line Of Credit
LineOfCredit
483601000 usd
CY2022Q4 us-gaap Line Of Credit
LineOfCredit
443217000 usd
CY2023Q1 us-gaap Senior Notes
SeniorNotes
1667114000 usd
CY2022Q4 us-gaap Senior Notes
SeniorNotes
1641552000 usd
CY2023Q1 us-gaap Unsecured Debt
UnsecuredDebt
99718000 usd
CY2022Q4 us-gaap Unsecured Debt
UnsecuredDebt
99692000 usd
CY2023Q1 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
16049000 usd
CY2022Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
14227000 usd
CY2023Q1 us-gaap Other Liabilities
OtherLiabilities
282958000 usd
CY2022Q4 us-gaap Other Liabilities
OtherLiabilities
236211000 usd
CY2023Q1 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
150873000 usd
CY2022Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
154867000 usd
CY2023Q1 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
264852000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
272248000 usd
CY2023Q1 us-gaap Finance Lease Liability
FinanceLeaseLiability
104544000 usd
CY2022Q4 us-gaap Finance Lease Liability
FinanceLeaseLiability
104218000 usd
CY2023Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
892984000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
895100000 usd
CY2023Q1 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
21768000 usd
CY2022Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
21569000 usd
CY2023Q1 us-gaap Security Deposit Liability
SecurityDepositLiability
50585000 usd
CY2022Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
50472000 usd
CY2023Q1 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
100000000 usd
CY2022Q4 us-gaap Junior Subordinated Debenture Owed To Unconsolidated Subsidiary Trust
JuniorSubordinatedDebentureOwedToUnconsolidatedSubsidiaryTrust
100000000 usd
CY2023Q1 us-gaap Liabilities
Liabilities
7361827000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
7260936000 usd
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
273175000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Common Carrying Amount
RedeemableNoncontrollingInterestEquityCommonCarryingAmount
269993000 usd
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
177943000 usd
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Preferred Carrying Amount
RedeemableNoncontrollingInterestEquityPreferredCarryingAmount
177943000 usd
CY2023Q1 us-gaap Preferred Stock Value
PreferredStockValue
221932000 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
221932000 usd
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000 shares
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000 shares
CY2023Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65433000 shares
CY2023Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65433000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
65440000 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
65440000 shares
CY2023Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1060000 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
1060000 shares
CY2023Q1 us-gaap Common Stock Value
CommonStockValue
656000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
656000 usd
CY2023Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3798101000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
3790358000 usd
CY2023Q1 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
128655000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
128655000 usd
CY2023Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
19428000 usd
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
49604000 usd
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
549024000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
651138000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
4460486000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
4585033000 usd
CY2023Q1 us-gaap Nonredeemable Noncontrolling Interest
NonredeemableNoncontrollingInterest
68688000 usd
CY2022Q4 us-gaap Nonredeemable Noncontrolling Interest
NonredeemableNoncontrollingInterest
61889000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4529174000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4646922000 usd
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12342119000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12355794000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
195042000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
156031000 usd
CY2023Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
9057000 usd
CY2022Q1 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
19888000 usd
CY2023Q1 us-gaap Other Income
OtherIncome
19476000 usd
CY2022Q1 us-gaap Other Income
OtherIncome
12045000 usd
CY2023Q1 us-gaap Revenues
Revenues
223575000 usd
CY2022Q1 us-gaap Revenues
Revenues
187964000 usd
CY2023Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
1000 usd
CY2022Q1 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
2523000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
52064000 usd
CY2022Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
42583000 usd
CY2023Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
41383000 usd
CY2022Q1 us-gaap Real Estate Tax Expense
RealEstateTaxExpense
30747000 usd
CY2023Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
6301000 usd
CY2022Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
6564000 usd
CY2023Q1 us-gaap Interest Expense Other
InterestExpenseOther
41653000 usd
CY2022Q1 us-gaap Interest Expense Other
InterestExpenseOther
15070000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2021000 usd
CY2022Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
1948000 usd
CY2023Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
78548000 usd
CY2022Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
46983000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
6890000 usd
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
0 usd
CY2023Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
884000 usd
CY2022Q1 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
28000 usd
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23285000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24776000 usd
CY2023Q1 slg Total Costs And Expenses Including Nonoperating Income Expense
TotalCostsAndExpensesIncludingNonoperatingIncomeExpense
253029000 usd
CY2022Q1 slg Total Costs And Expenses Including Nonoperating Income Expense
TotalCostsAndExpensesIncludingNonoperatingIncomeExpense
168699000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7412000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4715000 usd
CY2023Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-79000 usd
CY2022Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 usd
CY2023Q1 slg Purchase Price Fair Value Adjustment Gross
PurchasePriceFairValueAdjustmentGross
239000 usd
CY2022Q1 slg Purchase Price Fair Value Adjustment Gross
PurchasePriceFairValueAdjustmentGross
-63000 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-1651000 usd
CY2022Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-1002000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38357000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
13485000 usd
CY2023Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
-2337000 usd
CY2022Q1 us-gaap Noncontrolling Interest In Net Income Loss Operating Partnerships Redeemable
NoncontrollingInterestInNetIncomeLossOperatingPartnershipsRedeemable
492000 usd
CY2023Q1 us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
-1625000 usd
CY2022Q1 us-gaap Noncontrolling Interest In Net Income Loss Other Noncontrolling Interests Redeemable
NoncontrollingInterestInNetIncomeLossOtherNoncontrollingInterestsRedeemable
-143000 usd
CY2023Q1 us-gaap Noncontrolling Interest In Net Income Loss Preferred Unit Holders Redeemable
NoncontrollingInterestInNetIncomeLossPreferredUnitHoldersRedeemable
1598000 usd
CY2022Q1 us-gaap Noncontrolling Interest In Net Income Loss Preferred Unit Holders Redeemable
NoncontrollingInterestInNetIncomeLossPreferredUnitHoldersRedeemable
1647000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-35993000 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
11489000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3738000 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3738000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-39731000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7751000 usd
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.63
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.12
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.63
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.11
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64079000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64349000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68182000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70228000 shares
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38357000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
13485000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
-31059000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax
43567000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-968000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax
-1793000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-32027000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
41774000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-70384000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
55259000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-2364000 usd
CY2022Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
1996000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
-1851000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Noncontrolling Interest
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToNoncontrollingInterest
2277000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-66169000 usd
CY2022Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
50986000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4646922000 usd
CY2023Q1 slg Profit Loss Less Minority Interest In Net Income Loss Operating Partnerships
ProfitLossLessMinorityInterestInNetIncomeLossOperatingPartnerships
-37618000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-30176000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3738000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
184000 usd
CY2023Q1 slg Reallocationof Noncontrolling Interest In Operating Partnership Increase Decrease
ReallocationofNoncontrollingInterestInOperatingPartnershipIncreaseDecrease
-10147000 usd
CY2023Q1 slg Deferred Compensation Plan And Stock Award Net
DeferredCompensationPlanAndStockAwardNet
7559000 usd
CY2023Q1 slg Consolidation Of Joint Venture Interest
ConsolidationOfJointVentureInterest
8560000 usd
CY2023Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
136000 usd
CY2023Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.812
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
52236000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4529174000 usd
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4778253000 usd
CY2022Q1 slg Profit Loss Less Minority Interest In Net Income Loss Operating Partnerships
ProfitLossLessMinorityInterestInNetIncomeLossOperatingPartnerships
11346000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
39497000 usd
CY2022Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3738000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
89000 usd
CY2022Q1 slg Reallocationof Noncontrolling Interest In Operating Partnership Increase Decrease
ReallocationofNoncontrollingInterestInOperatingPartnershipIncreaseDecrease
-43023000 usd
CY2022Q1 slg Deferred Compensation Plan And Stock Award Net
DeferredCompensationPlanAndStockAwardNet
5056000 usd
CY2022Q1 us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
151197000 usd
CY2022Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
123000 usd
CY2022Q1 us-gaap Stock Issued During Period Value Stock Dividend
StockIssuedDuringPeriodValueStockDividend
160620000 usd
CY2022Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.932
CY2022Q1 us-gaap Dividends Common Stock
DividendsCommonStock
57665000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
4739115000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-38357000 usd
CY2022Q1 us-gaap Profit Loss
ProfitLoss
13485000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
80569000 usd
CY2022Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
48931000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-7412000 usd
CY2022Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-4715000 usd
CY2023Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
258000 usd
CY2022Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
188000 usd
CY2023Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
-79000 usd
CY2022Q1 us-gaap Equity Method Investment Realized Gain Loss On Disposal
EquityMethodInvestmentRealizedGainLossOnDisposal
0 usd
CY2023Q1 slg Purchase Price Fair Value Adjustment Gain Loss
PurchasePriceFairValueAdjustmentGainLoss
239000 usd
CY2022Q1 slg Purchase Price Fair Value Adjustment Gain Loss
PurchasePriceFairValueAdjustmentGainLoss
-63000 usd
CY2023Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-1651000 usd
CY2022Q1 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
-1002000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
6890000 usd
CY2022Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
0 usd
CY2023Q1 us-gaap Straight Line Rent
StraightLineRent
7431000 usd
CY2022Q1 us-gaap Straight Line Rent
StraightLineRent
546000 usd
CY2023Q1 slg Non Cash Lease Expense
NonCashLeaseExpense
5261000 usd
CY2022Q1 slg Non Cash Lease Expense
NonCashLeaseExpense
6043000 usd
CY2023Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
3271000 usd
CY2022Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
6964000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
969000 usd
CY2022Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13673000 usd
CY2023Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
-577000 usd
CY2022Q1 us-gaap Increase Decrease In Due From Related Parties Current
IncreaseDecreaseInDueFromRelatedPartiesCurrent
2335000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
3911000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Leasing Fees
IncreaseDecreaseInDeferredLeasingFees
4240000 usd
CY2023Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
11160000 usd
CY2022Q1 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
25076000 usd
CY2023Q1 slg Increase Decrease In Accrued Liabilities And Other
IncreaseDecreaseInAccruedLiabilitiesAndOther
4656000 usd
CY2022Q1 slg Increase Decrease In Accrued Liabilities And Other
IncreaseDecreaseInAccruedLiabilitiesAndOther
28049000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
2450000 usd
CY2022Q1 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
3550000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-2116000 usd
CY2022Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
864000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
42349000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
81402000 usd
CY2023Q1 slg Payments To Acquire Land Buildings And Improvements
PaymentsToAcquireLandBuildingsAndImprovements
61918000 usd
CY2022Q1 slg Payments To Acquire Land Buildings And Improvements
PaymentsToAcquireLandBuildingsAndImprovements
61680000 usd
CY2023Q1 slg Payments For Proceeds From Acquisition Deposits And Deferred Purchase Price
PaymentsForProceedsFromAcquisitionDepositsAndDeferredPurchasePrice
0 usd
CY2022Q1 slg Payments For Proceeds From Acquisition Deposits And Deferred Purchase Price
PaymentsForProceedsFromAcquisitionDepositsAndDeferredPurchasePrice
15000000 usd
CY2023Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
22985000 usd
CY2022Q1 us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
11399000 usd
CY2023Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
41812000 usd
CY2022Q1 us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
16089000 usd
CY2023Q1 us-gaap Proceeds From Real Estate And Real Estate Joint Ventures
ProceedsFromRealEstateAndRealEstateJointVentures
0 usd
CY2022Q1 us-gaap Proceeds From Real Estate And Real Estate Joint Ventures
ProceedsFromRealEstateAndRealEstateJointVentures
91994000 usd
CY2023Q1 slg Payments For Proceeds From Other Investments
PaymentsForProceedsFromOtherInvestments
17700000 usd
CY2022Q1 slg Payments For Proceeds From Other Investments
PaymentsForProceedsFromOtherInvestments
-209000 usd
CY2023Q1 slg Origination Of Debt And Preferred Equity Investments
OriginationOfDebtAndPreferredEquityInvestments
5578000 usd
CY2022Q1 slg Origination Of Debt And Preferred Equity Investments
OriginationOfDebtAndPreferredEquityInvestments
13122000 usd
CY2023Q1 slg Repayments Or Redemption Of Debt And Preferred Equity Investments
RepaymentsOrRedemptionOfDebtAndPreferredEquityInvestments
0 usd
CY2022Q1 slg Repayments Or Redemption Of Debt And Preferred Equity Investments
RepaymentsOrRedemptionOfDebtAndPreferredEquityInvestments
6405000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-66369000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
13496000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
0 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Secured Debt
ProceedsFromIssuanceOfSecuredDebt
5309000 usd
CY2023Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
1473000 usd
CY2022Q1 us-gaap Repayments Of Secured Debt
RepaymentsOfSecuredDebt
55715000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
143000000 usd
CY2022Q1 us-gaap Proceeds From Issuance Of Unsecured Debt
ProceedsFromIssuanceOfUnsecuredDebt
320000000 usd
CY2023Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
78000000 usd
CY2022Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
210000000 usd
CY2023Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
184000 usd
CY2022Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
89000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
CY2022Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
151197000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
0 usd
CY2022Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
17967000 usd
CY2023Q1 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
5220000 usd
CY2022Q1 us-gaap Payments For Repurchase Of Other Equity
PaymentsForRepurchaseOfOtherEquity
18272000 usd
CY2023Q1 slg Distributions To Noncontrolling Interests Other Partnerships
DistributionsToNoncontrollingInterestsOtherPartnerships
136000 usd
CY2022Q1 slg Distributions To Noncontrolling Interests Other Partnerships
DistributionsToNoncontrollingInterestsOtherPartnerships
123000 usd
CY2023Q1 slg Proceeds From Noncontrolling Interests In Other Partnerships
ProceedsFromNoncontrollingInterestsInOtherPartnerships
426000 usd
CY2022Q1 slg Proceeds From Noncontrolling Interests In Other Partnerships
ProceedsFromNoncontrollingInterestsInOtherPartnerships
0 usd
CY2023Q1 slg Distribution To Noncontrolling Interest Operating Partnership
DistributionToNoncontrollingInterestOperatingPartnership
3822000 usd
CY2022Q1 slg Distribution To Noncontrolling Interest Operating Partnership
DistributionToNoncontrollingInterestOperatingPartnership
4415000 usd
CY2023Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
57373000 usd
CY2022Q1 us-gaap Payments Of Dividends
PaymentsOfDividends
66339000 usd
CY2023Q1 slg Proceeds From Other Obligation Related To Secured Borrowing
ProceedsFromOtherObligationRelatedToSecuredBorrowing
0 usd
CY2022Q1 slg Proceeds From Other Obligation Related To Secured Borrowing
ProceedsFromOtherObligationRelatedToSecuredBorrowing
77874000 usd
CY2023Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
0 usd
CY2022Q1 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3888000 usd
CY2023Q1 slg Proceeds From Payments Of Financing Costs
ProceedsFromPaymentsOfFinancingCosts
358000 usd
CY2022Q1 slg Proceeds From Payments Of Financing Costs
ProceedsFromPaymentsOfFinancingCosts
-80000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-2772000 usd
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-124564000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-26792000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-29666000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
384054000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
336984000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
357262000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
307318000 usd
CY2023Q1 slg Issuance Of Special Dividend Stock Dividend
IssuanceOfSpecialDividendStockDividend
0 usd
CY2022Q1 slg Issuance Of Special Dividend Stock Dividend
IssuanceOfSpecialDividendStockDividend
160620000 usd
CY2023Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
0 usd
CY2022Q1 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8700000 usd
CY2023Q1 slg Operating Partnership Noncontrolling Interest Fair Value Adjustment
OperatingPartnershipNoncontrollingInterestFairValueAdjustment
10147000 usd
CY2022Q1 slg Operating Partnership Noncontrolling Interest Fair Value Adjustment
OperatingPartnershipNoncontrollingInterestFairValueAdjustment
43023000 usd
CY2023Q1 slg Contribution To Consolidated Joint Venture Interest
ContributionToConsolidatedJointVentureInterest
8134000 usd
CY2022Q1 slg Contribution To Consolidated Joint Venture Interest
ContributionToConsolidatedJointVentureInterest
0 usd
CY2023Q1 slg Removalof Fully Depreciated Real Estate Assets
RemovalofFullyDepreciatedRealEstateAssets
4247000 usd
CY2022Q1 slg Removalof Fully Depreciated Real Estate Assets
RemovalofFullyDepreciatedRealEstateAssets
651000 usd
CY2023Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
158937000 usd
CY2022Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
223674000 usd
CY2023Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
198325000 usd
CY2022Q1 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
83644000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
357262000 usd
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
307318000 usd
CY2023Q1 slg Numberof Real Estate Buildings
NumberofRealEstateBuildings
51 building
CY2023Q1 us-gaap Area Of Real Estate Property
AreaOfRealEstateProperty
29708910 sqft
CY2023Q1 slg Mortgage Loanson Real Estate Commercialand Consumer Net Including Debt Investments Other
MortgageLoansonRealEstateCommercialandConsumerNetIncludingDebtInvestmentsOther
626800000 usd
CY2023Q1 slg Debt Investments Other
DebtInvestmentsOther
8500000 usd
CY2023Q1 slg Number Of Shares On Redemption Of One Unit Of Partnership Interest
NumberOfSharesOnRedemptionOfOneUnitOfPartnershipInterest
1 shares
CY2023Q1 slg Rental Revenue Increase Decrease Acquired Lease Amortization
RentalRevenueIncreaseDecreaseAcquiredLeaseAmortization
-8200000 usd
CY2022Q1 slg Rental Revenue Increase Decrease Acquired Lease Amortization
RentalRevenueIncreaseDecreaseAcquiredLeaseAmortization
-100000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
403552000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
403552000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
203075000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
190066000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
200477000 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
213486000 usd
CY2023Q1 slg Finite Lived Intangible Liabilities Gross
FiniteLivedIntangibleLiabilitiesGross
361338000 usd
CY2022Q4 slg Finite Lived Intangible Liabilities Gross
FiniteLivedIntangibleLiabilitiesGross
361338000 usd
CY2023Q1 slg Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
222036000 usd
CY2022Q4 slg Finite Lived Intangible Liabilities Accumulated Amortization
FiniteLivedIntangibleLiabilitiesAccumulatedAmortization
212191000 usd
CY2023Q1 slg Finite Lived Intangible Liabilities Net
FiniteLivedIntangibleLiabilitiesNet
139302000 usd
CY2022Q4 slg Finite Lived Intangible Liabilities Net
FiniteLivedIntangibleLiabilitiesNet
149147000 usd
CY2023Q1 us-gaap Marketable Securities
MarketableSecurities
10273000 usd
CY2022Q4 us-gaap Marketable Securities
MarketableSecurities
11240000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2022Q1 us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
CY2022Q4 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
0 usd
CY2023Q1 us-gaap Equity Securities Fv Ni Current And Noncurrent
EquitySecuritiesFvNiCurrentAndNoncurrent
0 usd
CY2022Q1 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-100000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
800000 usd
CY2022Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
900000 usd
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from those estimates.</span></div>
CY2023Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentrations of Credit Risk</span></div><div style="margin-bottom:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash investments, debt and preferred equity investments and accounts receivable. We place our cash investments with high quality financial institutions. The collateral securing our debt and preferred equity investments is located in New York City. See Note 5, "Debt and Preferred Equity Investments." </span></div>We perform initial and ongoing evaluations of the credit quality of our tenants and require most tenants to provide security deposits or letters of credit. Though these security deposits and letters of credit are insufficient to meet the total value of a tenant's lease obligation, they are a measure of good faith and a potential source of funds to offset the economic costs associated with lost revenue from that tenant and the costs associated with re-tenanting a space.
CY2023Q1 slg Number Of Real Estate Properties Acquired From Third Party
NumberOfRealEstatePropertiesAcquiredFromThirdParty
0 property
CY2023Q1 slg Number Of Real Estate Properties Disposed
NumberOfRealEstatePropertiesDisposed
0 property
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
623280000 usd
CY2021Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
1088723000 usd
CY2023Q1 us-gaap Mortgage Loans On Real Estate Amortization Of Premium
MortgageLoansOnRealEstateAmortizationOfPremium
0 usd
CY2022 us-gaap Mortgage Loans On Real Estate Amortization Of Premium
MortgageLoansOnRealEstateAmortizationOfPremium
565940000 usd
CY2023Q1 slg Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Loan Loss Reserve Period Increase Decrease
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateLoanLossReservePeriodIncreaseDecrease
-6890000 usd
CY2022 slg Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Loan Loss Reserve Period Increase Decrease
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateLoanLossReservePeriodIncreaseDecrease
0 usd
CY2023Q1 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
626803000 usd
CY2022Q4 us-gaap Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
623280000 usd
CY2023Q1 us-gaap Mortgage Loans On Real Estate Commercial And Consumer Net
MortgageLoansOnRealEstateCommercialAndConsumerNet
626803000 usd
CY2023Q1 slg Mortgage Loanson Real Estate Senior Financing
MortgageLoansonRealEstateSeniorFinancing
1976821000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
6630000 usd
CY2021Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
6630000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
6890000 usd
CY2022 us-gaap Financing Receivable Excluding Accrued Interest Credit Loss Expense Reversal
FinancingReceivableExcludingAccruedInterestCreditLossExpenseReversal
0 usd
CY2023Q1 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
13520000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
6630000 usd
CY2023Q1 slg Financing Receivable Nonaccrual No Allowance Number
FinancingReceivableNonaccrualNoAllowanceNumber
2 loan
CY2022Q4 slg Number Of Investments Nonperforming
NumberOfInvestmentsNonperforming
2 investment
CY2023Q1 slg Number Of Investments Nonperforming
NumberOfInvestmentsNonperforming
2 investment
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
626803000 usd
CY2022Q4 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
623280000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
0 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
0 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
79865000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYear
546938000 usd
CY2023Q1 us-gaap Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
626803000 usd
CY2023Q1 slg Financing Receivable Excluding Accrued Interest Year Four Originated Three Years Before Current Fiscal Year Writeoff
FinancingReceivableExcludingAccruedInterestYearFourOriginatedThreeYearsBeforeCurrentFiscalYearWriteoff
6900000 usd
CY2023Q1 slg Financing Receivable Portfolio Segments Number
FinancingReceivablePortfolioSegmentsNumber
1 segment
CY2022 slg Financing Receivable Portfolio Segments Number
FinancingReceivablePortfolioSegmentsNumber
1 segment
CY2023Q1 us-gaap Financing Receivable Recorded Investment Nonaccrual Status
FinancingReceivableRecordedInvestmentNonaccrualStatus
5800000 usd
us-gaap Financing Receivable Nonaccrual Interest Income
FinancingReceivableNonaccrualInterestIncome
0 usd
CY2023Q1 srt Mortgage Loans On Real Estate Interest Rate
MortgageLoansOnRealEstateInterestRate
0.0574
CY2023Q1 slg Variable Interest Entity Not Primary Beneficiary Investment
VariableInterestEntityNotPrimaryBeneficiaryInvestment
79900000 usd
CY2022Q4 slg Variable Interest Entity Not Primary Beneficiary Investment
VariableInterestEntityNotPrimaryBeneficiaryInvestment
86200000 usd
CY2022Q4 us-gaap Equity Method Investments
EquityMethodInvestments
3190137000 usd
CY2023Q1 us-gaap Equity Method Investment Difference Between Carrying Amount And Underlying Equity
EquityMethodInvestmentDifferenceBetweenCarryingAmountAndUnderlyingEquity
562900000 usd
CY2023Q1 us-gaap Deferred Costs Leasing Gross
DeferredCostsLeasingGross
406407000 usd
CY2022Q4 us-gaap Deferred Costs Leasing Gross
DeferredCostsLeasingGross
407188000 usd
CY2023Q1 slg Accumulated Amortization Of Deferred Costs
AccumulatedAmortizationOfDeferredCosts
288805000 usd
CY2022Q4 slg Accumulated Amortization Of Deferred Costs
AccumulatedAmortizationOfDeferredCosts
286031000 usd
CY2023Q1 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
117602000 usd
CY2022Q4 us-gaap Deferred Costs Current And Noncurrent
DeferredCostsCurrentAndNoncurrent
121157000 usd
CY2023Q1 slg Secured Debt Bearing Fixed Interest Amount
SecuredDebtBearingFixedInterestAmount
3164341000 usd
CY2022Q4 slg Secured Debt Bearing Fixed Interest Amount
SecuredDebtBearingFixedInterestAmount
3165814000 usd
CY2023Q1 slg Secured Debt Bearing Variable Interest Amount
SecuredDebtBearingVariableInterestAmount
70148000 usd
CY2022Q4 slg Secured Debt Bearing Variable Interest Amount
SecuredDebtBearingVariableInterestAmount
70148000 usd
CY2023Q1 slg Secured Debt Gross
SecuredDebtGross
3234489000 usd
CY2022Q4 slg Secured Debt Gross
SecuredDebtGross
3235962000 usd
CY2023Q1 slg Secured Debt Deferred Finance Costs Net
SecuredDebtDeferredFinanceCostsNet
7708000 usd
CY2022Q4 slg Secured Debt Deferred Finance Costs Net
SecuredDebtDeferredFinanceCostsNet
8399000 usd
CY2023Q1 us-gaap Secured Debt
SecuredDebt
3226781000 usd
CY2022Q4 us-gaap Secured Debt
SecuredDebt
3227563000 usd
CY2023Q1 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
3800000000 usd
CY2022Q4 us-gaap Collateral Already Posted Aggregate Fair Value
CollateralAlreadyPostedAggregateFairValue
3800000000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
264502000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
962237000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
470000000 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
0 usd
CY2023Q1 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
3752750000 usd
CY2023Q1 slg Long Term Debt Maturity After Year Four
LongTermDebtMaturityAfterYearFour
150000000 usd
CY2023Q1 slg Long Term Debt Maturities Repayments Of Principal
LongTermDebtMaturitiesRepaymentsOfPrincipal
5599489000 usd
CY2023Q1 us-gaap Interest Expense
InterestExpense
64843000 usd
CY2022Q1 us-gaap Interest Expense
InterestExpense
32052000 usd
CY2023Q1 slg Finance Lease Interest Expense Before Capitalized Interest
FinanceLeaseInterestExpenseBeforeCapitalizedInterest
1106000 usd
CY2022Q1 slg Finance Lease Interest Expense Before Capitalized Interest
FinanceLeaseInterestExpenseBeforeCapitalizedInterest
1237000 usd
CY2023Q1 us-gaap Interest Costs Incurred Capitalized
InterestCostsIncurredCapitalized
25464000 usd
CY2022Q1 us-gaap Interest Costs Incurred Capitalized
InterestCostsIncurredCapitalized
17941000 usd
CY2023Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1487000 usd
CY2022Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
CY2023Q1 us-gaap Interest Income Operating
InterestIncomeOperating
319000 usd
CY2022Q1 us-gaap Interest Income Operating
InterestIncomeOperating
278000 usd
CY2023Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-41653000 usd
CY2022Q1 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
-15070000 usd
CY2023Q1 us-gaap Due From Joint Ventures
DueFromJointVentures
25976000 usd
CY2022Q4 us-gaap Due From Joint Ventures
DueFromJointVentures
26812000 usd
CY2023Q1 us-gaap Due From Other Related Parties
DueFromOtherRelatedParties
818000 usd
CY2022Q4 us-gaap Due From Other Related Parties
DueFromOtherRelatedParties
540000 usd
CY2023Q1 us-gaap Due From Related Parties
DueFromRelatedParties
26794000 usd
CY2022Q4 us-gaap Due From Related Parties
DueFromRelatedParties
27352000 usd
CY2023Q1 slg Total Shares Authorized
TotalSharesAuthorized
260000000 shares
CY2023Q1 slg Total Par Or Stated Value Per Share
TotalParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
160000000 shares
CY2023Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Excess Stock Shares Authorized
ExcessStockSharesAuthorized
75000000 shares
CY2023Q1 slg Excess Stock Par Or Stated Value Per Share
ExcessStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000 shares
CY2023Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q1 us-gaap Excess Stock Shares Outstanding
ExcessStockSharesOutstanding
0 shares
CY2023Q1 us-gaap Excess Stock Shares Issued
ExcessStockSharesIssued
0 shares
CY2017 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
7865206 shares
CY2017 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
107.81
CY2018 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
9187480 shares
CY2018 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
102.06
CY2019 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
4333260 shares
CY2019 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
88.69
CY2020 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
8276032 shares
CY2020 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
64.30
CY2021 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
4474649 shares
CY2021 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
75.44
CY2022 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
1971092 shares
CY2022 us-gaap Treasury Stock Acquired Average Cost Per Share
TreasuryStockAcquiredAverageCostPerShare
76.69
CY2023Q1 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-39731000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
7751000 usd
CY2023Q1 us-gaap Distributed Earnings
DistributedEarnings
406000 usd
CY2022Q1 us-gaap Distributed Earnings
DistributedEarnings
335000 usd
CY2023Q1 slg Net Income Loss Available To Common Stockholders After Distributed And Undistributed Earnings Allocation Basic
NetIncomeLossAvailableToCommonStockholdersAfterDistributedAndUndistributedEarningsAllocationBasic
-40137000 usd
CY2022Q1 slg Net Income Loss Available To Common Stockholders After Distributed And Undistributed Earnings Allocation Basic
NetIncomeLossAvailableToCommonStockholdersAfterDistributedAndUndistributedEarningsAllocationBasic
7416000 usd
CY2023Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
0 usd
CY2022Q1 us-gaap Undistributed Earnings Loss Allocated To Participating Securities Diluted
UndistributedEarningsLossAllocatedToParticipatingSecuritiesDiluted
96000 usd
CY2023Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
-2837000 usd
CY2022Q1 us-gaap Dilutive Securities Effect On Basic Earnings Per Share Other
DilutiveSecuritiesEffectOnBasicEarningsPerShareOther
492000 usd
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-42974000 usd
CY2022Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
7812000 usd
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64079000 shares
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
64349000 shares
CY2023Q1 slg Incremental Common Shares Attributable To Redemption Of Units To Common Shares
IncrementalCommonSharesAttributableToRedemptionOfUnitsToCommonShares
4103000 shares
CY2022Q1 slg Incremental Common Shares Attributable To Redemption Of Units To Common Shares
IncrementalCommonSharesAttributableToRedemptionOfUnitsToCommonShares
4121000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
984000 shares
CY2023Q1 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
0 shares
CY2022Q1 us-gaap Incremental Common Shares Attributable To Nonvested Shares With Forfeitable Dividends
IncrementalCommonSharesAttributableToNonvestedSharesWithForfeitableDividends
774000 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
68182000 shares
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
70228000 shares
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1275225 shares
CY2022Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
351927 shares
CY2023Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
400000 usd
CY2022Q1 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
300000 usd
CY2023Q1 slg Other Comprehensive Income Loss Deferred Net Lossfrom Terminated Hedges
OtherComprehensiveIncomeLossDeferredNetLossfromTerminatedHedges
-400000 usd
CY2022Q4 slg Other Comprehensive Income Loss Deferred Net Lossfrom Terminated Hedges
OtherComprehensiveIncomeLossDeferredNetLossfromTerminatedHedges
-500000 usd
CY2023Q1 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
10273000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
37082000 usd
CY2023Q1 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
15759000 usd
CY2022Q4 us-gaap Debt Securities Available For Sale Excluding Accrued Interest
DebtSecuritiesAvailableForSaleExcludingAccruedInterest
11240000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Asset
DerivativeFairValueOfDerivativeAsset
57660000 usd
CY2022Q4 us-gaap Derivative Fair Value Of Derivative Liability
DerivativeFairValueOfDerivativeLiability
10142000 usd
CY2023Q1 us-gaap Derivative Net Liability Position Aggregate Fair Value
DerivativeNetLiabilityPositionAggregateFairValue
16400000 usd
CY2023Q1 us-gaap Assets Needed For Immediate Settlement Aggregate Fair Value
AssetsNeededForImmediateSettlementAggregateFairValue
17100000 usd
CY2023Q1 us-gaap Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths
-38500000 usd
CY2023Q1 slg Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months Into Equity In Net Income
CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonthsIntoEquityInNetIncome
-9700000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
-19408000 usd
CY2022Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification And Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
38686000 usd
CY2023Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net
InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
-11651000 usd
CY2022Q1 us-gaap Interest Rate Cash Flow Hedge Gain Loss Reclassified To Earnings Net
InterestRateCashFlowHedgeGainLossReclassifiedToEarningsNet
4881000 usd
CY2022Q1 us-gaap Revenues
Revenues
187964000 usd
CY2023Q1 slg Income Loss From Continuing Operations Before Realized Gain Loss On Disposal Of Equity Method Investment
IncomeLossFromContinuingOperationsBeforeRealizedGainLossOnDisposalOfEquityMethodInvestment
-38357000 usd
CY2023Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
166353000 usd
CY2022Q1 us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
136581000 usd
CY2023Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
20450000 usd
CY2022Q1 us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
19555000 usd
CY2023Q1 slg Operating Lease Lease Income Fixed And Variable Lease Payments
OperatingLeaseLeaseIncomeFixedAndVariableLeasePayments
186803000 usd
CY2022Q1 slg Operating Lease Lease Income Fixed And Variable Lease Payments
OperatingLeaseLeaseIncomeFixedAndVariableLeasePayments
156136000 usd
CY2023Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
8239000 usd
CY2022Q1 us-gaap Amortization Of Above And Below Market Leases
AmortizationOfAboveAndBelowMarketLeases
-105000 usd
CY2023Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
195042000 usd
CY2022Q1 us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
156031000 usd
CY2023Q1 us-gaap Sublease Income
SubleaseIncome
48900000 usd
CY2022Q1 us-gaap Sublease Income
SubleaseIncome
56200000 usd
CY2023Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
1106000 usd
CY2022Q1 us-gaap Sales Type Lease Interest Income
SalesTypeLeaseInterestIncome
1092000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q1 us-gaap Revenues
Revenues
223575000 usd
CY2022Q1 slg Income Loss From Continuing Operations Before Realized Gain Loss On Disposal Of Equity Method Investment
IncomeLossFromContinuingOperationsBeforeRealizedGainLossOnDisposalOfEquityMethodInvestment
13485000 usd
CY2023Q1 us-gaap Assets
Assets
12342119000 usd
CY2022Q4 us-gaap Assets
Assets
12355794000 usd
CY2023Q1 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segment
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
23300000 usd
CY2022Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
24800000 usd

Files In Submission

Name View Source Status
0001040971-23-000020-index-headers.html Edgar Link pending
0001040971-23-000020-index.html Edgar Link pending
0001040971-23-000020.txt Edgar Link pending
0001040971-23-000020-xbrl.zip Edgar Link pending
a23q110qex31.htm Edgar Link pending
a23q110qex311.htm Edgar Link pending
a23q110qex312.htm Edgar Link pending
a23q110qex313.htm Edgar Link pending
a23q110qex314.htm Edgar Link pending
a23q110qex321.htm Edgar Link pending
a23q110qex322.htm Edgar Link pending
a23q110qex323.htm Edgar Link pending
a23q110qex324.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R81.htm Edgar Link pending
R82.htm Edgar Link pending
R83.htm Edgar Link pending
R84.htm Edgar Link pending
R85.htm Edgar Link pending
R86.htm Edgar Link pending
R87.htm Edgar Link pending
R88.htm Edgar Link pending
R89.htm Edgar Link pending
R9.htm Edgar Link pending
R90.htm Edgar Link pending
R91.htm Edgar Link pending
R92.htm Edgar Link pending
R93.htm Edgar Link pending
R94.htm Edgar Link pending
R95.htm Edgar Link pending
R96.htm Edgar Link pending
R97.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
slg-20230331.htm Edgar Link pending
slg-20230331.xsd Edgar Link pending
slg-20230331_def.xml Edgar Link unprocessable
slg-20230331_lab.xml Edgar Link unprocessable
slg-20230331_cal.xml Edgar Link unprocessable
slg-20230331_pre.xml Edgar Link unprocessable
slg-20230331_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable